Key Metabolic Enzymes Involved in Remdesivir Activation in Human Lung CellsRuidong Li, Joy Y. Feng, Bernard P. Murray et al.|Antimicrobial Agents and Chemotherapy|2021Cited by 63
Pharmacokinetics and Disposition of Momelotinib Revealed a Disproportionate Human Metabolite—Resolution for Clinical DevelopmentJim Zheng, Jeffrey A. Silverman, Raju Subramanian et al.|Drug Metabolism and Disposition|2018Cited by 56
Lenacapavir: A Novel, Potent, and Selective First-in-Class Inhibitor of HIV-1 Capsid Function Exhibits Optimal Pharmacokinetic Properties for a Long-Acting Injectable Antiretroviral AgentRaju Subramanian, Bill J. Smith, Jennifer Tang et al.|Molecular Pharmaceutics|2023Cited by 52
Inhaled remdesivir reduces viral burden in a nonhuman primate model of SARS-CoV-2 infectionMeghan S. Vermillion, Danielle Porter, Eisuke Murakami et al.|Science Translational Medicine|2021Cited by 42
Intravenous delivery of GS-441524 is efficacious in the African green monkey model of SARS-CoV-2 infectionJared Pitts, John P. Bilello, Darius Babusis et al.|Antiviral Research|2022Cited by 13